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Objectives The aim of the study was to assess the influence of percutaneous coronary intervention (PCI) and therapeutic
hypothermia (TH) on long-term prognosis.
Background Although hospital care consisting of TH and/or PCI in particular patients resuscitated following out-of-hospital
cardiac arrest (OHCA) can improve survival to hospital discharge, there is little evidence regarding how these
therapies may impact long-term prognosis.
Methods We performed a cohort investigation of all persons 18 years of age who suffered nontraumatic OHCA and
were resuscitated and discharged alive from the hospital between January 1, 2001, and December 31, 2009, in
a metropolitan emergency medical service (EMS) system. We reviewed EMS and hospital records, state death
certificates, and the national death index to determine clinical characteristics and vital status. Survival analyses
were conducted using Kaplan-Meier estimates and multivariable Cox regression. Analyses of TH were restricted
to those patients who were comatose at hospital admission.
Results Of the 5,958 persons who received EMS-attempted resuscitation, 1,001 (16.8%) were discharged alive from the
hospital. PCI was performed in 384 of 1,001 (38.4%), whereas TH was performed in 241 of 941 (25.6%) per-
sons comatose at hospital admission. Five-year survival was 78.7% among those treated with PCI compared
with 54.4% among those not receiving PCI and 77.5% among those treated with TH compared with 60.4%
among those not receiving TH (both p  0.001). After adjustment for confounders, PCI was associated with a
lower risk of death (hazard ratio [HR]: 0.46 [95% confidence interval [CI]: 0.34 to 0.61]; p  0.001). Likewise,
TH was associated with a lower risk of death (HR: 0.70 [95% CI: 0.50 to 0.97]; p  0.04).
Conclusions The findings suggested that effects of acute hospital interventions for post-resuscitation treatment extend
beyond hospital survival and can positively influence prognosis following the arrest hospitalization.
(J Am Coll Cardiol 2012;60:21–7) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.03.036Out-of-hospital cardiac arrest (OHCA) is a leading cause of
death worldwide (1,2). Opportunities to improve OHCA
survival, and in turn, public health depend in part on the
chain of survival. The links in the chain include early
activation of emergency response, early cardiopulmonary
resuscitation (CPR), early defibrillation, expert advanced
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2012, accepted March 20, 2012.therapies, and integrated post-resuscitation care (3). In-
creasing evidence supports a role for hospital-based inter-
ventions that can reverse the underlying cause of arrest and
limit ischemia-reperfusion injury that often occurs in
OHCA (4). Evidence-based guidelines indicate that hospi-
tal care consisting of therapeutic hypothermia (TH) (5–8)
and/or percutaneous coronary intervention (PCI) (9,10) in
particular patients can improve functional hospital survival
(5–8,10,11).
However, there is little evidence regarding how these
therapies may impact long-term prognosis. Ultimately, an
optimal public health assessment of therapy reflects both
short- and long-term treatment effects. We hypothesized
that the potential short-term survival benefit of hospital-
based interventions of TH and PCI following OHCA
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duction in mortality following
hospital discharge.
Methods
Study design, population, and
setting. We performed a cohort
investigation of all patients aged
18 years who experienced non-
traumatic OHCA and were re-
suscitated and discharged alive
from the hospital between Janu-
ary 1, 2001, and December 31,
2009, in a large metropolitan
emergency medical service (EMS)
system. The study was approved
by the appropriate review boards. The EMS system serves a
population of approximately 1.3 million persons residing in
urban, suburban, and rural settings covering an area of about
2,000 square miles. The EMS is a 2-tiered system com-
posed of basic life support provided by emergency medical
technician–trained firefighters equipped with automated
external defibrillators and advanced life support delivered by
paramedics who are trained in rhythm recognition and
provide intubation, manual defibrillation, and intravenous
medications (12). Patients are brought to 1 of 13 hospitals.
Each hospital has a coronary catheterization laboratory and
intensive care services. Hospital-based patient care is at the
direction and discretion of the treating physician team.
Data collection and definitions. The EMS system main-
tains an ongoing registry of all EMS-treated cardiac arrests.
Information about demographics, circumstances, presenting
arrest rhythm, arrest etiology, clinical characteristics, care,
and outcome is collected using emergency dispatch, EMS,
and hospital records. The information is organized accord-
ing to the Utstein Guidelines for reporting OHCA (13).
We collected data about hospital interventions and their
indications. Specifically, we collected information about
TH, PCI, implantable cardioverter defibrillator (ICD),
neurological status upon hospital arrival, and ST-segment
elevation myocardial infarction (MI) on initial hospital elec-
trocardiogram. Comatose status was based on review of the
EMS, emergency department, and admitting records. ST-
segment elevation infarction was defined as elevation of 1
mm in 2 contiguous limb leads and 2 mm in 2 contiguous
precordial leads. Characteristics were abstracted without
knowledge of outcome status.
Outcome. The primary outcome was vital status following
discharge from the hospital. We ascertained vital status by
linking participant information with both state vital records
(death certificates) through December 31, 2009, and the
National Social Security Death Index through December
31, 2010.















hypothermiawith proportions and compared them using the Pearsonchi-square test or Fisher exact text if appropriate. Contin-
uous variables were described with either their median (25th
to 75th percentile) or their mean SD and compared using
he nonparametric Wilcoxon test.
Entry into the cohort began at hospital discharge.
ollow-up was censored at the date of death or up to
ecember 31, 2010. Analyses specifically evaluating PCI
nd survival included all patients. Analyses investigating the
elationship between TH and survival were restricted to
hose who were comatose at hospital admission and would
herefore be considered eligible for TH. Survival was esti-
ated by the Kaplan-Meier product-limit method. Com-
arisons between groups were performed using the log-rank
r stratified log-rank test when appropriate. We evaluated
urvival according to TH status and PCI status separately
nd then evaluated survival simultaneously according to the
exclusive TH and PCI groups.
To evaluate the independent association of TH and PCI
ith long-term survival, we used Cox regression to perform
multivariable analysis that included potential confounders.
he model initially included demographic characteristics.
ubsequent models progressively included pre-hospital and
linical characteristics to test the robustness of the observed
Figure 1 Flow Chart
This figure shows how patients who experienced out-of-hospital cardiac arrest
(OHCA) during the study period (2001 to 2009) were dispatched and the inves-
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July 3, 2012:21–7 Prognosis of Arrest With Hypothermia/PCIhazard ratios (HRs). Models also adjusted for calendar year
or truncated after 5 years of follow-up to assess whether
general temporal patterns could account for PCI or TH
associations.
We assessed subgroups defined by initial rhythm (shock-
able/nonshockable) and ST-segment elevation MI (yes/no)
by including an interaction term between the intervention
and subgroup in the multivariable model. We also evaluated
the PCI association among those who received the PCI
urgently, defined as PCI within 6 h of hospital arrival.
In a separate set of analyses designed to address potential
confounding in the relationships between TH and survival
and between PCI and survival, we conducted a nested
case–control cohort study with counter-matching design.
This analytic design matches those with and without the
exposure of interest across confounders adapted on survival
analysis and then compares survival (14,15). Finally, we
addressed potential confounding by using multivariable
logistic regression to derive a propensity score to predict
treatment with PCI or TH. We adjusted the association
between the intervention and survival with the propensity
to receive the intervention. We also stratified the patients
according to the propensity score, matched patients according
to their intervention status (intervention/intervention), and
then compared survival. All tests were 2-sided with p  0.05
considered statistically significant. We performed analyses
using STATA/SE 11.0 software (College Station, Texas).





TH 245 (24.5) 86 (23.7)
PCI 384 (38.7)
ICD 300 (30.0) 100 (26.1)
VF 688 (68.8) 347 (90.4)
Cardiac etiology 791 (79.1) 382 (99.5)
Male 691 (69.1) 312 (81.3)
Median age, yrs 61 (52–73) 59 (52–70)
History of coronary disease 379 (36.5) 137 (35.7)
Hypertension 585 (58.5) 206 (53.7)
Diabetes mellitus 286 (28.6) 77 (20.0)
Dyslipidemia 389 (38.9) 174 (45.3)
Active smoking 274 (27.4) 132 (34.4)
Cardiomyopathy 244 (24.4) 45 (11.7)
Previous coronary angiogram 282 (28.2) 100 (26.0)
Previous PCI 145 (14.5) 75 (19.5)
Previous CABG 142 (14.2) 52 (13.5)
Median EMS interval, min 5 (4–6) 5 (4–6)
Bystander CPR 462 (46.2) 183 (47.7)
Witnessed 844 (84.4) 355 (92.5)
Home location 574 (57.6) 187 (48.7)
Public location 345 (34.5) 173 (45.1)
Facilities location 78 (7.8) 24 (6.3)
Values are n (%) or median (quartile 1 to quartile 3). *Restricted to those who were comatose at
CABG  coronary artery bypass graft; CPR  cardiopulmonary resuscitation; ICD  implantable-card
F  ventricular fibrillation.Results
Population. During the study period, 16.8% (1,001 of
5,958) of patients 18 years of age were discharged alive
from the hospital following EMS-treated, nontraumatic
OHCA (Fig. 1). The length of hospitalization was 8 (5 to
14) days, and 85% of the cohort had a favorable outcome of
cerebral performance category 1 or 2 at the time of hospital
discharge. Among this cohort of OHCA hospital survivors,
384 of 1,001 (38.4%) received a PCI during the arrest
hospitalization. Six percent (60 of 1,001) were conscious at
hospital admission and so were not eligible for TH. Among
the 941 eligible for TH, 245 of 941 (26.0%) received TH
during the arrest hospitalization. A smaller subset—9.1%
(86 of 941)—received both PCI and TH. PCI occurred
within 6 h of hospital arrival in 306 of 384 patients (80%).
Among those who received PCI within 6 h, 217 of 306
(70.9%) had evidence of ST elevation on the initial hospital
12-lead electrocardiogram. For TH-treated patients, the
mean time to reach target temperature34°C was 5.7 5.5 h,
he mean length of treatment was 21.0  9.3 h, and the
owest mean temperature was 32.8°C  1.2°C.
aseline characteristics. Overall, two-thirds of the study
ohort were male, and the median age was 61 years
Table 1). Nearly 80% (791 of 1,001) had a cardiac etiology,
nd nearly 70% (688 of 1,001) presented with an initial
hockable rhythm. Compared with those who did not






(n  696) p Value
(27.9) 0.23
94 (36.6) 290 (39.5) 0.42
(32.4) 0.03 95 (38.8) 186 (26.8) 0.001
(55.3) 0.001 205 (83.7) 445 (64.0) 0.001
(66.3) 0.001 222 (90.6) 526 (75.7) 0.001
(61.4) 0.001 189 (77.1) 456 (65.6) 0.001
(52–74) 0.06 59 (49–69) 62 (52–74) 0.001
(39.2) 0.26 87 (35.5) 251 (36.1) 0.87
(61.4) 0.02 137 (55.9) 410 (59.0) 0.40
(33.9) 0.001 68 (27.8) 200 (28.8) 0.76
(34.9) 0.001 101 (41.2) 258 (37.1) 0.26
(23.0) 0.001 63 (25.7) 192 (27.6) 0.56
(32.3) 0.001 54 (22.0) 172 (24.8) 0.40
(29.5) 0.24 75 (29.2) 206 (27.7) 0.65
(11.5) 0.001 28 (10.9) 117 (15.8) 0.06
(14.8) 0.59 42 (16.3) 99 (13.3) 0.23
(4–6) 0.92 5 (4–6) 5 (4–6) 0.24
(45.2) 0.45 148 (60.4) 284 (40.8) 0.001
(79.8) 0.001 206 (84.1) 587 (84.8) 0.78
(63.1) 0.001 138 (56.3) 403 (58.3) 0.04
(28.1) 96 (39.2) 228 (33)
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Prognosis of Arrest With Hypothermia/PCI July 3, 2012:21–7male, be younger, have an arrest due to a cardiac etiology,
have a public location arrest, receive bystander CPR, and
present with an initial shockable rhythm (Table 1). In
addition, those who received PCI were more likely to have
a witnessed arrest as well as clinically recognized cardiovas-
cular risk factors and coronary disease. In the comparison
according to TH status, those who received TH demon-
strated similar relationships with regard to sex, age, arrest
etiology, arrest location, bystander CPR status, and present-
ing rhythm. There were no observed differences in PCI
status according to TH status or TH status according to
PCI status.
Survival. During 3,800.7 person-years of follow-up, there
ere 348 deaths. Overall, survival was 86.9% (869 of 1,001)
t 6 months, 82.2% (822 of 1,001) at 1 year, and 64.1% (641
f 1,001) at 5 years. Survival was better for those who
eceived PCI compared with those who did not receive PCI
log-rank p  0.001) (Fig. 2A). Similarly, survival was
better for those receiving TH compared with those who did
not receive TH (log-rank p  0.001) (Fig. 2B). When
stratified into 4 exclusive groups according to TH and PCI
status, those who received neither treatment had the lowest
1-year and 5-year survival estimates, whereas those who
received both TH and PCI had the highest 1-year and
5-year survival estimates (stratified log-rank p  0.001)
(Fig. 2C).
In the multivariable model, PCI, TH, and ICD were
each independently associated with a better prognosis
(Table 2). In the full model, PCI was associated with a
lower risk of death (HR: 0.46 [95% confidence interval
[CI]: 0.34 to 0.61]) as was TH (HR: 0.70 [95% CI: 0.50 to
0.98]). Associations of TH and PCI did not appear to be a
consequence of overall temporal changes in long-term
survival. Associations for each intervention were similar
when adjusted for calendar year (model 5) or when the
cohort was truncated at 5 years of follow-up (model 6).
Interaction terms between clinical subsets (ST-segment
elevation MI and initial rhythm) and primary exposures
(PCI and TH) were not significant and so did not
indicate evidence of differences in association according
to subgroups. However, the confidence intervals crossed 1
for some of the subgroup associations. The HR of death
associated with PCI was 0.41 (95% CI: 0.21 to 0.77)
among those with ST-segment elevation MI and 0.55
(95% CI: 0.38 to 0.78) among those without ST-segment
elevation MI. The HR of death associated with TH was
0.62 (95% CI: 0.41 to 0.93) among those with a shock-
able arrest rhythm and 0.89 (95% CI: 0.51 to 1.55)
among those with a nonshockable rhythm. When the
PCI exposure was restricted to those who underwent PCI
within 6 h of hospital admission, the HR of death
associated with “urgent” PCI was 0.36 (95% CI: 0.25 to
0.50).
The nested cohort was built for each intervention to
enable a comparison matched on potential confounders
and time at risk. There were 45 pairs for TH/no TH andFigure 2 Kaplan-Meier Survival Estimates
(A) The curves represent survival rates according to percutaneous coronary
intervention (PCI) performance (log-rank p  0.001). (B) The curves represent
survival rates according to receiving or not receiving the mild therapeutic hypo-
thermia (TH) (log-rank p  0.001). (C) The curves represent survival rates
according to receiving or not receiving the combination of treatments
(PCI and/or TH) (log-rank p  0.001).
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onstrated favorable outcome associations for TH and
PCI (Table 3).
Similarly, the beneficial association was evident when
adjusting for the propensity score for PCI (HR: 0.60 [95%
CI: 0.44 to 0.81]) and for TH (HR: 0.70 [95% CI: 0.50 to
0.98]) and when the comparison was stratified by propensity
score and matched on intervention status.
Discussion
An optimal assessment of medical therapy attempts to
measure both short- and long-term treatment effects (16).
Although evidence supports short-term survival benefits of
TH and PCI in specific post-arrest populations, there is
little information about how these hospital-based interven-
tions may affect long-term prognosis. In this population-
based cohort of patients resuscitated from OHCA who
survived to hospital discharge, 5-year survival was 79%
among those who received PCI and 54% among those who
did not receive PCI. Similar survival relationships were
observed for TH; 5-year survival was 78% among those who





PCI 0.33 (0.26–0.43) 0.001
TH* 0.68 (0.49–0.94) 0.02
ICD 0.51 (0.40–0.66) 0.001
Model 2
PCI 0.38 (0.29–0.51) 0.001
TH* 0.70 (0.50–0.97) 0.03
ICD 0.61 (0.45–0.82) 0.002
Model 3
PCI 0.46 (0.34–0.61) 0.001
TH* 0.70 (0.50–0.98) 0.04
ICD 0.54 (0.40–0.73) 0.001
Model 4
PCI 0.51 (0.37–0.69) 0.001
TH* 0.65 (0.46–0.91) 0.01
ICD 0.68 (0.49–0.94) 0.02
Model 5
PCI 0.53 (0.39–0.72) 0.001
TH* 0.67 (0.46–0.97) 0.04
ICD 0.68 (0.49–0.94) 0.02
Model 6
PCI 0.55 (0.40–0.76) 0.001
TH* 0.67 (0.47–0.95) 0.02
ICD 0.55 (0.39–0.76) 0.001
*Restricted to comatose patients. Model 1 was adjusted for age and sex. Model 2 was adjusted for
age, sex, initial rhythm, etiology, arrest location, witnessed, bystander CPR, and emergency
medical service (EMS) response interval. Model 3 was adjusted for age, sex, initial rhythm, etiology,
arrest location, witnessed, bystander CPR, EMS response interval, diabetes mellitus, dyslipidemia,
smoking, hypertension, previous cardiomyopathy, etiology, and coronary disease history. Model 4
was the same as model 3 plus adjustment for cerebral performance category score at hospital
discharge. Model 5 was the same as model 4 plus adjustment for year of cohort entry. Model 6 was
the same as model 4 using exit time of the study up to 5 years.
Abbreviations as in Table 1.received TH and 60% among those who did not receiveTH. These long-term protective associations were robust
and evident in multivariable models and nested case–cohort
analyses designed to account for confounding in this obser-
vational cohort study.
Long-term survival was substantial, with an overall 5-year
survival rate of 64% among a group whose mean age was 61
years at cohort entry. Importantly, the cohort included all
patients who were resuscitated from OHCA and discharged
from the hospital regardless of etiology or functional status
at discharge in an effort to provide a representative commu-
nity experience that would maximize generalizability.
Taken together, the overall long-term survival is encour-
aging and indicates that initial efforts that help achieve
survival to hospital discharge can result in considerable
long-term survival and measurable public health reduc-
tion in mortality.
We specifically evaluated the prognostic role of interven-
tional hospital therapies. The placement of an ICD was
associated with improved long-term survival, a finding
consistent with the results of randomized controlled trials
(17). The comparability between the association observed in
the current study and the survival effects determined in
previous ICD trials of secondary prevention suggested that
the treatment associations observed in the current study are
valid.
We focused on the long-term prognostic influence of
PCI and TH and observed an independent survival benefit
associated with each intervention. PCI in patients with
transmural infarction can potentially provide long-term
survival benefits through a variety of mechanisms, such as a
reduction of recurrent ischemia and preservation of myo-
cardial function (18–20). However the long-term survival
influence of PCI in a large comprehensive cohort of OHCA
survivors is less established. Prior studies have indicated
survival benefit at 6 months or among select smaller groups
of OHCA survivors (21). We observed a beneficial PCI
survival association that was evident early after discharge
and continued to accrue over 5 years of follow-up.
Although approximately three-quarters of PCIs occurred
among those with evidence of ST-elevation MI, a quarter of
PCIs was performed among those without ST-elevation
MI. A beneficial survival association was evident among
those with and without ST-elevation MI. This finding is
provocative given the current debate about whether patients
without evidence of ST elevation following resuscitation can
benefit from PCI and should undergo early and routine
coronary catheterization (10,22,23). The current study
suggested that PCI—performed at the discretion of the
cardiologist—can provide long-term survival benefits. Im-
portantly, the current study cannot definitively characterize
those patients without ST elevation who are most likely to
benefit from PCI.
We also observed a long-term survival benefit associated
with TH. The mechanism by which hypothermia provides
early benefit is not fully defined, although cooling appears to
reduce systemic ischemia-reperfusion injury and help pre-
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studies have suggested that recovery from neurological injury
after resuscitation from OHCA can take many months
(24,25). Given this protracted time course of neurological
recovery, one hypothesis is that TH in the acute phase
may benefit more convalescent phases of physiological
recovery (26).
We also stratified survival into 4 treatment groups based
on the combination of PCI and TH and found that patients
treated with both interventions had the highest long-term
survival, those treated with one or the other had an
intermediate long-term prognosis, and those treated with
neither had the lowest survival. Prior studies have indi-
cated that the 2 therapies can be safely combined and may
provide additive short-term survival benefit (27–30). The
current results suggested that this additive benefit may
extend long term. The finding that distinct interventions
improved long-term outcome supports a multidisciplinary
hospital approach that could coordinate multiple treatments
(31–33).
Study limitations. The study population was an incep-
tion cohort of those who survived to hospital discharge
following OHCA resuscitation. As a consequence, we
were not able to evaluate the potential in-hospital effects
of PCI and TH. However, multiple studies have evalu-
ated the short-term outcomes associated with these
therapies, although few have evaluated the long-term
prognostic implications. The study was observational; there-
fore, we cannot be sure that the associations were causal. For
example, we were not able to adjust for medication treat-
ments, which can influence prognosis. To help address
Counter-Matching Nested Case–Control CohortTable 3 Counter-Matching Nested Case–Control Cohort
TH (n  45) TH (n  45)
Time at risk 1.2 1.6 1.2 1.6
Male 38 (84.4) 38 (84.4)
Age, yrs 65.1 11.6 64.8 11.9
Witnessed 42 (93.3) 42 (93.3)
Bystander CPR 26 (57.8) 26 (57.8)
VF 35 (77.8) 35 (77.8)
Diabetes mellitus 18 (40) 18 (40)
Dyslipidemia 19 (42.2) 17 (37.8)
Hypertension 29 (64.4) 31 (68.9)
Active smoking 11 (24.4) 11 (24.4)
Coronary disease 25 (55.6) 19 (42.2)
Cardiomyopathy 16 (35.6) 16 (35.6)
Time response 4.93 1.5 4.74 1.77
PCI 11 (24.4) 11 (24.4)
TH
ICD 16 (35.6) 15 (33.3)
Home location 26 (57.8) 27 (60)
Public location 18 (40) 14 (31.1)
Facilities location 1 (2.2) 4 (8.9)
Deaths 14 (31) 31 (69)
Values are mean  SD or n (%).
Abbreviations as in Table 1.potential confounding, models included a range of demo-graphic and clinical covariates including the common indi-
cations for medication treatments (i.e., coronary artery
disease, congestive heart failure). We found that the bene-
ficial associations of PCI and TH were robust to a variety of
analyses designed to account for confounding, including the
matched nested cohort analysis. We did not have detailed
information about the type of hypothermia or the extent of
PCI—information that might help delineate how these
interventions provided benefit. We did not detect a differ-
ence in the intervention-outcome relationship according to
clinical subgroups. However, these analyses had limited
power to detect subgroup differences. Although the inves-
tigation included all patients who survived to hospital
discharge and involved a large metropolitan region served by
a mix of academic and community-based hospitals, we
cannot be certain that the results will generalize to other
communities or health systems. For example, all of the
receiving hospitals in the study community have a catheter-
ization laboratory and intensive care services. We do not
have information about functional status or quality of life
during the follow-up period, although the majority was
discharged with a favorable cerebral performance category
score of 1 or 2.
Conclusions
In this population-based cohort of patients discharged
alive from the hospital following OHCA, we observed a
long-term survival benefit associated with PCI and TH
therapies provided during the OHCA hospitalization.
The findings suggested that the effects of acute hospital
lue PCI (n  46) PCI (n  46) p Value
0 2.0 2.3 2.0 2.3 1.00
0 35 (76.1) 35 (76.1) 1.00
5 69.0 11.8 69.2 11.1 0.68
0 45 (97.8) 45 (97.8) 1.00
0 21 (45.7) 21 (45.7) 1.00
0 41 (89.1) 41 (89.1) 1.00
0 16 (34.8) 16 (34.8) 1.00
6 30 (65.2) 30 (65.2) 1.00
2 37 (80.4) 37 (80.4) 1.00
0 11 (23.9) 11 (23.9) 1.00
4 27 (58.7) 23 (50) 0.39
0 14 (30.4) 14 (30.4) 1.00
5 5.2 1.33 5.0 1.7 0.52
0
4 (8.7) 4 (8.7) 1.00
3 15 (32.6) 15 (32.6) 1.00
9 27 (58.7) 24 (52.2) 0.26
17 (37.0) 15 (32.6)
2 (4.4) 7 (15.2)
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July 3, 2012:21–7 Prognosis of Arrest With Hypothermia/PCIextend beyond initial hospital survival and influence prog-
nosis following the arrest hospitalization. Thus, the optimal
measure of these therapies may incorporate short- and
long-term outcomes. The challenge then is to identify those
who will and those who will not benefit from such inter-
ventions to maximize health benefit, minimize risk, and use
resources efficiently.
Reprint requests and correspondence: Dr. Florence Dumas, Emer-
gency Medical Services Division of Public Health, 401 5th Avenue, Suite
1200, Seattle, Washington 98104. E-mail: florence.dumas@cch.aphp.fr.
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